Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bahrami
Ali Bahrami, Sammamish, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20080313162 | METHODS AND SYSTEMS FOR CONTEXT BASED QUERY FORMULATION AND INFORMATION RETRIEVAL - A method for context-based query formulation and information retrieval and aggregation is described. The method includes modeling one or more workflow activities utilized to perform work tasks, preparing at least one meta-querying template, to generate queries that utilize the modeled workflow activities, retrieving information relevant to the work task as determined utilizing the at least one meta-querying template, and aggregating the retrieved information for presentation to the user. | 12-18-2008 |
| 20100262451 | Simplified Approach for Service Composition and Orchestration - The different advantageous embodiments provide a method, apparatus, and computer program product for improved workflow management. A workflow model is executed. The workflow model may include a number of worklets. Each worklet in the number of worklets may have a number of associated assistlets. A determination is made as to whether a number of associated assistelets for a first worklet in the number of worklets execute during execution of the workflow model. In response to a determination that the number of associated assistlets for the first worklet execute, the number of associated assistlets for the first worklet are executed. | 10-14-2010 |
Ali Bahrami, Boulder, CO US
| Patent application number | Description | Published |
|---|---|---|
| 20110113409 | SYMBOL CAPABILITIES SUPPORT WITHIN ELF - Systems and methods for efficient compilation and execution of program code. A compiler generates a plurality of families of object files, wherein each family comprises a set of system capabilities different from a set of another family. A link-editor receives the object files and stores a symbol capabilities table in a symbol capabilities section of an object file with a new file format. A symbol is associated with one or more instances, wherein each instance is associated with a different set of capabilities. In various embodiments, system capabilities may include a particular operating system, special-function additional instructions, or otherwise. Subsequent to creation of the single object file with multiple instances of a given function, a runtime linker chooses a given instance based on the capabilities of the platform on which the code is to be executed. | 05-12-2011 |
Hamed Bahrami, Isfahan IR
| Patent application number | Description | Published |
|---|---|---|
| 20090242783 | Non-Radioactive Electron Capture Detector for GC - Electron capture detector for use with an effluent stream from a gas chromatograph includes a non-radioactive electron source means and an adjacent ionization chamber in which electron capture take place. The detector comprises two partial chambers, of which one contains the electron source, and the other contains connections for input and output of analysis gas as well as a collector electrode for detecting ions. The collector electrode and the electron source are each of cylindrical configurations, and are coaxially aligned but are spaced apart with respect to each other. The electron current to the collector electrode provides an indication of the presence of electronegative constituents in the gas passing into the second partial chamber. | 10-01-2009 |
Hassan Bahrami, Lexington, KY US
| Patent application number | Description | Published |
|---|---|---|
| 20090166944 | Duplex Architecture For An Imaging Apparatus - An imaging apparatus including an image transfer device, a first motor, a redrive section and a duplexing section. The first motor is drivingly connected to the image transfer device. The reversible redrive section is downstream from the image transfer device, and the reversible redrive section includes a second motor. The duplexing section includes a third motor. The duplexing section is positioned to receive media from the redrive section. The first motor, the second motor and the third motor are each independently controlled. | 07-02-2009 |
Mehdi Bahrami, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20100236664 | APPARATUS AND METHODS FOR CONTROLLED DEBARKING OF WOOD - An apparatus for determining one or more optimal operating parameters for debarking wood is provided. The apparatus has a scraper and an actuator configured to adjust the position of the scraper toward a sample portion of the wood to scrape a surface of the sample portion of the wood with a scraping force. The apparatus also has a force sensor operatively associated with the scraper for detecting the scraping force. A light source impinges light on a scraped surface of the sample portion. A light detector detects a light image defined by light from the light source reflected by the scraped surface. A controller is operatively associated with the force sensor and the light detector. The controller has processing means to determine the one or more optimal operating parameters based on signals relating to the scraping force and signals relating to the light image. The one or more optimal operating parameters are relevant to debarking wood proximal to the sample portion. | 09-23-2010 |
S. Bahram Bahrami, Emeryville, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080279780 | Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancer - A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate. | 11-13-2008 |
| 20100330589 | NEEDLE ARRAY ASSEMBLY AND METHOD FOR DELIVERING THERAPEUTIC AGENTS - A fluid delivery device includes an array of needles, each in fluid communication with a respective reservoir. Respective actuators are coupled so as to be operable to drive fluid from the reservoirs via needle ports. Each needle can have a plurality of ports, and the ports can be arranged to deliver a substantially equal amount of fluid at any given location along its length. A driver is coupled to the actuators to selectively control the rate, volume, and direction of flow of fluid through the needles. The device can simultaneously deliver a plurality of fluid agents along respective axes in solid tissue in vivo. If thereafter resected, the tissue can be sectioned for evaluation of an effect of each agent on the tissue, and based on the evaluation, candidate agents selected or deselected for clinical trials or therapy, and subjects selected or deselected for clinical trials or therapeutic treatment. | 12-30-2010 |
| 20110230839 | Needle Array Assembly and Method for Delivering Therapeutic Agents - A fluid delivery device includes an array of needles, each in fluid communication with a respective reservoir. Respective actuators are coupled so as to be operable to drive fluid from the reservoirs via needle ports. Each needle can have a plurality of ports, and the ports can be arranged to deliver a substantially equal amount of fluid at any given location along its length. A driver is coupled to the actuators to selectively control the rate, volume, and direction of flow of fluid through the needles. The device can simultaneously deliver a plurality of fluid agents along respective axes in solid tissue in vivo. If thereafter resected, the tissue can be sectioned for evaluation of an effect of each agent on the tissue, and based on the evaluation, candidate agents selected or deselected for clinical trials or therapy, and subjects selected or deselected for clinical trials or therapeutic treatment. | 09-22-2011 |
| 20120087866 | NEEDLE ARRAY ASSEMBLY AND METHOD FOR DELIVERING THERAPEUTIC AGENTS - A fluid delivery device includes an array of needles, each in fluid communication with a respective reservoir. Respective actuators are coupled so as to be operable to drive fluid from the reservoirs via needle ports. Each needle can have a plurality of ports, and the ports can be arranged to deliver a substantially equal amount of fluid at any given location along its length. A driver is coupled to the actuators to selectively control the rate, volume, and direction of flow of fluid through the needles. The device can simultaneously deliver a plurality of fluid agents along respective axes in solid tissue in vivo. If thereafter resected, the tissue can be sectioned for evaluation of an effect of each agent on the tissue, and based on the evaluation, candidate agents selected or deselected for clinical trials or therapy, and subjects selected or deselected for clinical trials or therapeutic treatment. | 04-12-2012 |
| 20120089095 | NEEDLE ARRAY ASSEMBLY AND METHOD FOR DELIVERING THERAPEUTIC AGENTS - A fluid delivery device includes an array of needles, each in fluid communication with a respective reservoir. Respective actuators are coupled so as to be operable to drive fluid from the reservoirs via needle ports. Each needle can have a plurality of ports, and the ports can be arranged to deliver a substantially equal amount of fluid at any given location along its length. A driver is coupled to the actuators to selectively control the rate, volume, and direction of flow of fluid through the needles. The device can simultaneously deliver a plurality of fluid agents along respective axes in solid tissue in vivo. If thereafter resected, the tissue can be sectioned for evaluation of an effect of each agent on the tissue, and based on the evaluation, candidate agents selected or deselected for clinical trials or therapy, and subjects selected or deselected for clinical trials or therapeutic treatment. | 04-12-2012 |
| 20120094866 | NEEDLE ARRAY ASSEMBLY AND METHOD FOR DELIVERING THERAPEUTIC AGENTS - A fluid delivery device includes an array of needles, each in fluid communication with a respective reservoir. Respective actuators are coupled so as to be operable to drive fluid from the reservoirs via needle ports. Each needle can have a plurality of ports, and the ports can be arranged to deliver a substantially equal amount of fluid at any given location along its length. A driver is coupled to the actuators to selectively control the rate, volume, and direction of flow of fluid through the needles. The device can simultaneously deliver a plurality of fluid agents along respective axes in solid tissue in vivo. If thereafter resected, the tissue can be sectioned for evaluation of an effect of each agent on the tissue, and based on the evaluation, candidate agents selected or deselected for clinical trials or therapy, and subjects selected or deselected for clinical trials or therapeutic treatment. | 04-19-2012 |
Shervin Bahrami, Aarhus C DK
| Patent application number | Description | Published |
|---|---|---|
| 20090324553 | Chimeric Viral Envelopes - The invention relates to chimeric polytropic viral envelope polypeptides and uses thereof, as well as to polynucleotides encoding said chimeric polypeptides and constructs comprising said polypeptides and/or polynucleotides. The invention also relates to chimeric retroviral envelope polypeptides, polynucleotides and vectors encoding said chimeric retroviral envelope polypeptides, virus particles and cells harbouring said chimeric envelope polypeptides. Said chimeric polypeptide comprise an envelope polypeptide, or fragment thereof, and a polypeptide sequence of a receptor binding region, ligand or polypeptide sequence of a ligand binding region, and optionally a linker sequence. The invention include methods of targeting receptors, methods of treatment and methods for delivery of agents using said chimeric retroviral envelope polypeptides. The invention is applicable for directed targeting and controlled fusion of virus particles with other cellular membranes. | 12-31-2009 |
Shervin Bahrami, Arhus C DK
| Patent application number | Description | Published |
|---|---|---|
| 20110305749 | HIV-1 Envelope Polypeptides for HIV Vaccine - Immunogenic HIV-1 envelope polypeptides are provided, wherein specific amino acid residues are mutated to repress immunosuppression in GP41, thereby boosting the immune response against HIV-1. Specifically, mutation of those specific residues does not affect the fusogenic properties of the viral particle and/or the overall protein structure of the viral envelope protein. The invention further provides peptides and antigens based on the immunogenic HIV-1 envelopes as well as nucleic acid sequences and vectors encoding those. Moreover, biological entities such as viral particles are provided, as well as use of the provided components for preparation of a vaccine against HIV-1/AIDS. | 12-15-2011 |
Soheyl Bahrami, Gotzendorf AT
| Patent application number | Description | Published |
|---|---|---|
| 20120094314 | DIAGNOSIS OF SEPTIC COMPLICATIONS - The invention describes a method for diagnosing of septic complications in polytraumatised human or animal patients, said patients being free of traumatic brain injury, by determining the level of the C-type natriuretic peptide (CNP), its precursors or fragments thereof, especially the precursor of the C-type natriuretic peptide (NT-proCNP), in this patient and diagnosing the patient a having septic complications or being at risk of developing septic complications, if the level of CNP, its precursors or fragments thereof, especially NT-proCNP, is increased compared to normal levels. | 04-19-2012 |
Taraneh Bahrami, San Jose, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110154079 | Instruction For Enabling A Procesor Wait State - In one embodiment, the present invention includes a processor having a core with decode logic to decode an instruction prescribing an identification of a location to be monitored and a timer value, and a timer coupled to the decode logic to perform a count with respect to the timer value. The processor may further include a power management unit coupled to the core to determine a type of a low power state based at least in part on the timer value and cause the processor to enter the low power state responsive to the determination. Other embodiments are described and claimed. | 06-23-2011 |